期刊文献+

慢病毒介导RNA干扰HPIP蛋白抑制肿瘤细胞增殖 被引量:2

Lentiviral-Mediated Knock-Down of Human HPIP Inhibits Cell Growth and Proliferation
下载PDF
导出
摘要 目的:建立高效稳定的造血相关的PBX相互作用蛋白质(HPIP)小干扰RNA(siRNA)细胞导入方法,检测HPIP的表达对肿瘤细胞生长增殖的影响。方法:构建人HPIP慢病毒siRNA干扰载体,将重组质粒转染人胚肾293T细胞,通过实时定量RT-PCR及Western印迹分析检测Lenti-H1 HPIP siRNA的干扰效果;将Lenti-H1 HPIPsiRNA与4个包装质粒共同转染293T细胞,包装成慢病毒后,感染宫颈癌HeLa和肝癌HepG2细胞,经嘌呤霉素筛选2周后,收集细胞进行Western印迹检测;用结晶紫实验检测其对肿瘤细胞生长增殖的影响。结果:构建的Lenti-H1 HPIP siRNA能有效抑制HPIP的表达;结晶紫实验显示,慢病毒介导的HPIP siRNA导致细胞增殖的显著抑制。结论:慢病毒介导的HPIP敲减能明显抑制肿瘤细胞的增殖,HPIP可能是一个潜在的肿瘤治疗新靶点。 Objective:To establish an efficient and stable way to deliver hematopoietic PBX-interacting protein(HPIP) small interfering RNA(siRNA) and examine the effect of HPIP siRNA on cell proliferation.Methods:pLenti-H1/HPIP siRNA was constructed and transfected into 293T cells.Western blot and real-time RT-PCR were carried out to detect the inhibitory effect of Lenti-H1 HPIP siRNA.The four viral packaging vectors together with pLenti-H1/HPIP siRNA were used to transfect 293T cells to produce lentivirus particles.After HeLa and HepG2 cells were infected with the obtained viruses and screened for 2 weeks with puromicin,the expression of HPIP was examined by Western blot analysis.Crystal violet assay was performed to investigate the effect of lentivirus on tumor growth and proliferation.Results:Western blot and real-time RT-PCR showed that pLenti-H1/HPIP siRNA could suppress the expression level of HPIP.Crystal violet analysis showed that down-regulation of HPIP could obviously suppress cell growth and proliferation.Conclusion:pLenti-H1/HPIP siRNA can significantly inhibit the expression of HPIP and suppress cell growth and proliferation.HPIP might serve as a novel target for cancer therapy.
出处 《生物技术通讯》 CAS 2011年第3期321-324,共4页 Letters in Biotechnology
基金 国家自然科学基金(30800205和31071174) 国家重大科学研究计划(2007CB914603) 全军医药卫生科研基金(06J021)
关键词 造血相关的PBX相互作用蛋白质 RNA干扰 慢病毒 细胞增殖 hematopoietic PBX-interacting protein lentivirus small interfering RNA cell proliferation
  • 相关文献

参考文献12

  • 1Abramovich C, Shen W F, Pineauh N, et al. Functional cloning and characterization of a novel nonhomeodomain prorein that inhibits the binding of PBX1-HOX complexes to DNA[J]. Biol Chem, 2000,275(34):26172-26177.
  • 2Abramovich C, Chavez E A, Lansdorp P M, et al. Functional characterization of multiple domains involved in the subcellular localization of the hematopoietic Pbx interacting protein(HPIP) [J]. Oncogene, 2002,21(44):6766-6771.
  • 3Manavathi B, Acconcia F, Rayala S K, et al. An inherent role of microtubule network in the action of nuclear receptor [J]. Proc Natl Acad Sci USA, 2006,103(43):15981-15986.
  • 4Wang X, Yang Z, Zhang H, et al. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT[J]. Biochim Biophys Acta, 2008,1783(6):1220-1228.
  • 5Banan M, Puri N. The ins and outs of RNAi in mammalian cells[J]. Curt Pharm Biotechnol, 2004,5(5):441-450.
  • 6Sinn P L, Santer S L, McCray P B Jr. Genetherapy progress and prospects: development of improved lentiviral and retroviral vectors design, biosaftey and production[J]. Gene Ther, 2005,12 (14):1089-1098.
  • 7Elbashir S M, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells[J]. Nature, 2001,411(6836):494-498.
  • 8Scherr M, Morgan M A, Eder M. Gene silencing mediated by small interfering RNAs in mammalian cells[J]. Curr Med Chem, 2003,10(3):245-256.
  • 9Han Juqiang, Ding Lihua, Yuan Bin, et al. Hepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cells[J]. Nucleic Acids Res, 2006,34(10):3095-3106.
  • 10Zhang Hao, Xie Xiangyang, Zhu Xudong, et al. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells[J]. Biol Chem, 2005,280(52):43188-43197.

同被引文献44

  • 1Siegel R, Ma J, Zou Z, et al. Cancer statistics, 20,14 [ J ]. CA Cancer J Clin, 2014, 64(1): 9-29.
  • 2Okada S, Irie T, Tanaka J, et al. Potential role of hematopoietic pre-B-cell leukemia transcription factor-interacting protein in oral carcinogenesis [ J ]. J Oral Pathol Med, 2014,23 (6) : 17-25.
  • 3Karamese M, Aksak S, Gundogdu OB, et al. A new hypothesis a- bout hematopoietic Pbx-interaction protein ( HPIP ) : can it be a key factor in neurodegeneration in the post-menopausal period.'? [J]. Med Hypotheses, 2013, 81(3): 470-476.
  • 4Abramo,Jich C, Chavez EA, Lansdorp PM, et at. Functional characterization of multiple domains involved in the subcellular lo- calization of the hematopoietic Pbx interacting protein ( HPIP ) [J]. Oneogene, 2002, 21(44): 6766-6771.
  • 5Manavathi B, Lo D, Bugide S, et al. Functional regulation of pre- B-cell leukemia homeobox interacting protein 1 (PBXIP1/HPIP) in erythroid differentiation [ J ]. J Biol Chem, 2012, 287 ( 8 ) : 5600-5614.
  • 6Boonyaratanakornkit V. Scaffolding proteins mediating membrane- initiated extra-nuclear actions of estrogen receptor [ J ]. Steroids, 2011, 76(9): 877-884.
  • 7Abramovich C, Shen WF, Pineault N, et al. Functional cloning and characterization of a novel nonhomeodomain protein that in- hibits the binding of PBX1-HOX complexes to DNA [ J]. J Biol Chem, 2000, 275(34): 26172-26177.
  • 8Xu X, Fan Z, Kang L, et al. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis [ J ]. J Clin Invest, 2013, 123(2): 630-645.
  • 9Manavathi B, Acconcia F, Rayala SK, et al. An inherent role of microtubule network in the action of nuclear receptor [ J ]. Proc Natl Aead Sci U S A, 2006, 103(43) : 15981-15986.
  • 10Ding L, Niu C, Zheng Y, et al. FHL1 interacts with oestrogen re- ceptors and regulates breast cancer cell growth [ J ]. J Cell Mol Med, 2011, 15(1): 72-85.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部